Timing of delivery following selective laser photocoagulation for twin-to-twin transfusion syndrome

Department of Obstetrics and Maternal-Fetal Medicine, GHU Necker-Enfants Malades, Université Paris Descartes, France.
American journal of obstetrics and gynecology (Impact Factor: 4.7). 08/2012; 207(2):127.e1-6. DOI: 10.1016/j.ajog.2012.06.042
Source: PubMed


We sought to compare intrauterine risks with postnatal outcome in monochorionic pregnancies operated by fetoscopic laser surgery for twin-to-twin transfusion syndrome.
A cohort of 602 consecutive cases was analyzed. Unexpected prenatal adverse events were identified when a fatal or potentially fatal event occurred that could have been avoided by timely delivery.
The prospective risk of an unexpected adverse event dropped from 16.8% (95% confidence interval [CI], 13.6-20.5%) to 0% (95% CI, 0-11%) between 26-36 weeks. At 32 weeks, the residual risk was 1 in 17 (95% CI, 1/28-1/11). The perinatal rate of death or severe brain lesions dropped from 35% (25-47%) in infants delivered at 26-28 weeks down to 3% (1-6%) at 34-36 weeks.
Our results did not identify an optimal cut-off for elective preterm delivery in laser-operated twin-to-twin transfusion syndrome. Perinatal morbidity appears low from ≥32 weeks and the decision for elective delivery should be based upon medical history, parental demand, and expert assessment.

17 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Congenital birth defects and early/premature birth are common complex conditions affecting populations throughout the world, the interaction of which accounts for a significant proportion of neonatal morbidity and mortality. The relationship between these two conditions is not well understood. Several congenital birth defects can directly lead to early delivery. In addition, certain fetal conditions may necessitate early or premature delivery, several of which are also associated with maternal conditions necessitating early birth. Further understanding of both the incidences and causes of congenital birth defects and of early and premature birth will facilitate establishment of strategies to improve neonatal mortality and morbidity.
    Clinics in perinatology 12/2013; 40(4):629-44. DOI:10.1016/j.clp.2013.07.009 · 2.44 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The improvements in fetal diagnosis or imaging, maternal-fetal anaesthesia, and instrumenta-tion have resulted in a wider application of fetal surgery for complex fetal diseases of the fetal patient in order to prevent death and to improve the quality of life for long-term survivors. However, for all decisions the maternal risks have to be balanced and considered in the informed consent process. Sometimes symptoms of the fetal disease may overlap with risks of the procedures. Maternal symptoms may even improve after fetal surgery in some cases. Here we aim at illustrating the short- and long-term consequences of different procedures of fetal surgery in order to improve the indication and informed consent process with the parents. Interdisciplinary team approaches help to illustrate the fetal, neonatal and maternal consequences when discussing and indicating fetal surgery and hopefully facilitate a long-term support for the family.
    Zeitschrift für Geburtshilfe und Neonatologie 04/2014; 218(2):64-73. DOI:10.1055/s-0034-1368787 · 0.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: With the recognition of the role of fetoscopic laser ablation for twin to twin transfusion syndrome (TTTS), there is a requirement for auditable standards for this technically challenging and specialized treatment. The purpose of this study is to report on the perinatal and medium-term neurodevelopmental outcomes following an 8-year national single center experience in the management of TTTS using the selective fetoscopic laser ablation technique. An audit of all cases of TTTS treated with selective laser ablation by a single national fetal medicine team was performed. Overall perinatal survival and medium-term neurodevelopmental outcomes were reported and correlated with gestational age at diagnosis, placental location, volume of amnio-reduction, Quintero staging and percentage inter-twin growth discordance. Procedure-related complications were recorded. The overall fetal survival for the first 105 consecutive cases of TTTS was 61% (128/210 fetuses). Dual survival occurred in 47% (49/105) of cases, and with a single survival rate of 28% (30/105), perinatal survival of least one infant was achieved in 75% (79/105) of cases. No correlation was found between any clinical or sonographic marker and perinatal outcome, although dual survival was noted to be significantly decreased with increasing Quintero stage (p=0.041). Currently, 86% of survivors have been reported to have a normal medium-term neurological outcome. Fetoscopic laser ablation is the established optimal treatment for severe twin to twin transfusion syndrome (TTTS). We report comparable short and medium-term outcomes following the selective fetoscopic technique comparing results from our national program with internationally published single-center outcomes, supporting the efficacy and safety of this treatment at our center. Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
    European Journal of Obstetrics & Gynecology and Reproductive Biology 05/2015; 191. DOI:10.1016/j.ejogrb.2015.05.019 · 1.70 Impact Factor